Cita APA (7a ed.)

Sagara, R., Ishigaki, M., Otsuka, M., Murayama, K., Ida, H., & Fernandez, J. (2021). Long-term safety and effectiveness of velaglucerase alfa in Gaucher disease: 6-year interim analysis of a post-marketing surveillance in Japan. BMC.

Cita Chicago Style (17a ed.)

Sagara, Rieko, Masahide Ishigaki, Manami Otsuka, Kei Murayama, Hiroyuki Ida, y Jovelle Fernandez. Long-term Safety and Effectiveness of Velaglucerase Alfa in Gaucher Disease: 6-year Interim Analysis of a Post-marketing Surveillance in Japan. BMC, 2021.

Cita MLA (8a ed.)

Sagara, Rieko, et al. Long-term Safety and Effectiveness of Velaglucerase Alfa in Gaucher Disease: 6-year Interim Analysis of a Post-marketing Surveillance in Japan. BMC, 2021.